A new HIV vaccine has shown promise in Phase I trials. “The vaccine successfully stimulated the production of the rare immune cells needed to generate antibodies against HIV in 97 percent of participants.”
Advertise here with Carbon Ads
This site is made possible by member support. 💞
Big thanks to Arcustech for hosting the site and offering amazing tech support.
When you buy through links on kottke.org, I may earn an affiliate commission. Thanks for supporting the site!
kottke.org. home of fine hypertext products since 1998.
Stay Connected